As an alternative, and to overcome these limitations, the cell line CLL-CD134, derived from a canine chronic lymphocytic leukemia and transduced with feline CD134 was developed [38]. This evidence concerns the gene TNFRSF4 and B-cell chronic lymphocytic leukemia.